These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992 [TBL] [Abstract][Full Text] [Related]
3. Unusual complications in a patient receiving streptokinase treatment for deep venous thrombosis. McGregor J; Roach AC Crit Care Nurse; 1981; 1(7):53-5. PubMed ID: 6918261 [No Abstract] [Full Text] [Related]
4. Anticoagulant therapy for deep vein thrombosis: its proper application. Rohrer MJ; Anderson FA Semin Vasc Surg; 1996 Mar; 9(1):13-20. PubMed ID: 8665021 [No Abstract] [Full Text] [Related]
5. Psoas muscle hematoma--an acute compartment syndrome. Report of a case. Al-Zamil A; Christenson JT Vasa; 1988; 17(2):141-3. PubMed ID: 3407316 [No Abstract] [Full Text] [Related]
6. Rethrombosis--warfarin or low-dose heparin? Wessler S; Gitel SN N Engl J Med; 1979 Oct; 301(16):889-91. PubMed ID: 384252 [No Abstract] [Full Text] [Related]
7. [Prevention of the recurrences of deep venous thromboses of the legs using calcium heparin in slowly decreasing dosages]. Bilancini S; Lucchi M Angiologia; 1988; 40(4):125-8. PubMed ID: 3177941 [No Abstract] [Full Text] [Related]
8. Improving use of heparin in acute deep venous thrombosis. Gold JA; Ferguson CJ; Williams NF; Braun SK Wis Med J; 1996 May; 95(5):311-2. PubMed ID: 8936037 [No Abstract] [Full Text] [Related]
9. Adverse reactions associated with heparin therapy for ischemic heart disease and thrombophlebitis. Mishler JM Am J Hosp Pharm; 1973 Dec; 30(12):1158-61. PubMed ID: 4763223 [No Abstract] [Full Text] [Related]
10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
11. [Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis]. Vorob'eva NM; Ermolina OV; Balakhonova TV; Dobrovol'skiĭ AB; Titaeva EV; Kirienko AI; Panchenko EP Ter Arkh; 2008; 80(7):50-4. PubMed ID: 18763596 [TBL] [Abstract][Full Text] [Related]
12. [Ambulatory treatment without complications. A 1-year experience in distal deep-vein thrombosis]. Svensson P; Lethagen S; Lindén E; Berntorp E Lakartidningen; 1994 Aug; 91(34):2950-2. PubMed ID: 7990537 [No Abstract] [Full Text] [Related]
13. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation. Ascani A; Iorio A; Agnelli G Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621 [TBL] [Abstract][Full Text] [Related]
14. Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin? Jaff MR Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S17-21. PubMed ID: 19213061 [TBL] [Abstract][Full Text] [Related]